These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 30184175)

  • 41. Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage.
    Martin SW; Pawloski L; Williams M; Weening K; DeBolt C; Qin X; Reynolds L; Kenyon C; Giambrone G; Kudish K; Miller L; Selvage D; Lee A; Skoff TH; Kamiya H; Cassiday PK; Tondella ML; Clark TA
    Clin Infect Dis; 2015 Jan; 60(2):223-7. PubMed ID: 25301209
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of Bordetella pertussis isolates collected in Japan before and after introduction of acellular pertussis vaccines.
    Guiso N; Boursaux-Eude C; Weber C; Hausman SZ; Sato H; Iwaki M; Kamachi K; Konda T; Burns DL
    Vaccine; 2001 Apr; 19(23-24):3248-52. PubMed ID: 11312021
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pertussis: Identification, Prevention and Control.
    Stefanelli P
    Adv Exp Med Biol; 2019; 1183():127-136. PubMed ID: 31321754
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in the genomic content of circulating Bordetella pertussis strains isolated from the Netherlands, Sweden, Japan and Australia: adaptive evolution or drift?
    King AJ; van Gorkom T; van der Heide HG; Advani A; van der Lee S
    BMC Genomics; 2010 Jan; 11():64. PubMed ID: 20102608
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surveillance of Circulating Bordetella pertussis Strains in Europe during 1998 to 2015.
    Barkoff AM; Mertsola J; Pierard D; Dalby T; Hoegh SV; Guillot S; Stefanelli P; van Gent M; Berbers G; Vestrheim DF; Greve-Isdahl M; Wehlin L; Ljungman M; Fry NK; Markey K; Auranen K; He Q
    J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29491017
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs.
    Hallander HO; Advani A; Donnelly D; Gustafsson L; Carlsson RM
    J Clin Microbiol; 2005 Jun; 43(6):2856-65. PubMed ID: 15956409
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Significant gene order and expression differences in Bordetella pertussis despite limited gene content variation.
    Brinig MM; Cummings CA; Sanden GN; Stefanelli P; Lawrence A; Relman DA
    J Bacteriol; 2006 Apr; 188(7):2375-82. PubMed ID: 16547023
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance.
    Dorji D; Mooi F; Yantorno O; Deora R; Graham RM; Mukkur TK
    Med Microbiol Immunol; 2018 Feb; 207(1):3-26. PubMed ID: 29164393
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Whole-genome sequencing reveals the effect of vaccination on the evolution of Bordetella pertussis.
    Xu Y; Liu B; Gröndahl-Yli-Hannuksila K; Tan Y; Feng L; Kallonen T; Wang L; Peng D; He Q; Wang L; Zhang S
    Sci Rep; 2015 Aug; 5():12888. PubMed ID: 26283022
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bordetella pertussis pertactin knock-out strains reveal immunomodulatory properties of this virulence factor.
    Hovingh ES; Mariman R; Solans L; Hijdra D; Hamstra HJ; Jongerius I; van Gent M; Mooi F; Locht C; Pinelli E
    Emerg Microbes Infect; 2018 Mar; 7(1):39. PubMed ID: 29559630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Short-Read Whole-Genome Sequencing for Laboratory-Based Surveillance of Bordetella pertussis.
    Marchand-Austin A; Tsang RSW; Guthrie JL; Ma JH; Lim GH; Crowcroft NS; Deeks SL; Farrell DJ; Jamieson FB
    J Clin Microbiol; 2017 May; 55(5):1446-1453. PubMed ID: 28228490
    [No Abstract]   [Full Text] [Related]  

  • 52. Engineering of an Iranian
    Nikbin VS; Keramati M; Noofeli M; Tayebzadeh F; Kahali B; Shahcheraghi F
    J Med Microbiol; 2020 Jan; 69(1):111-119. PubMed ID: 31778110
    [No Abstract]   [Full Text] [Related]  

  • 53. Bordetella pertussis strain variation and evolution postvaccination.
    Kallonen T; He Q
    Expert Rev Vaccines; 2009 Jul; 8(7):863-75. PubMed ID: 19538113
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulating B. pertussis isolates.
    Gzyl A; Augustynowicz E; Gniadek G; Rabczenko D; Dulny G; Slusarczyk J
    Vaccine; 2004 Jun; 22(17-18):2122-8. PubMed ID: 15149768
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effectiveness of experimental whole-cell pertussis vaccines in murine model.
    Polak M; Zawadka M; Mosiej E; Rabczenko D; Augustynowicz E; Lutyńska A
    Med Dosw Mikrobiol; 2014; 66(2):79-87. PubMed ID: 25369654
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bordetella pertussis isolates in Finland: serotype and fimbrial expression.
    Heikkinen E; Xing DK; Olander RM; Hytönen J; Viljanen MK; Mertsola J; He Q
    BMC Microbiol; 2008 Sep; 8():162. PubMed ID: 18816412
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pertactin negative Bordetella pertussis demonstrates higher fitness under vaccine selection pressure in a mixed infection model.
    Safarchi A; Octavia S; Luu LD; Tay CY; Sintchenko V; Wood N; Marshall H; McIntyre P; Lan R
    Vaccine; 2015 Nov; 33(46):6277-81. PubMed ID: 26432908
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of Adenylate Cyclase Toxoid Antigen in Acellular Pertussis Vaccines by Using a Bordetella pertussis Challenge Model in Mice.
    Boehm DT; Hall JM; Wong TY; DiVenere AM; Sen-Kilic E; Bevere JR; Bradford SD; Blackwood CB; Elkins CM; DeRoos KA; Gray MC; Cooper CG; Varney ME; Maynard JA; Hewlett EL; Barbier M; Damron FH
    Infect Immun; 2018 Oct; 86(10):. PubMed ID: 30012638
    [No Abstract]   [Full Text] [Related]  

  • 59. Pertactin deficient Bordetella pertussis present a better fitness in mice immunized with an acellular pertussis vaccine.
    Hegerle N; Dore G; Guiso N
    Vaccine; 2014 Nov; 32(49):6597-600. PubMed ID: 25312274
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increase in pertussis cases along with high prevalence of two emerging genotypes of Bordetella pertussis in Perú, 2012.
    Bailon H; León-Janampa N; Padilla C; Hozbor D
    BMC Infect Dis; 2016 Aug; 16():422. PubMed ID: 27530444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.